Ruxolitinib
CAS: 941678-49-5
Ref. 3D-FR27771
| 1g | 391.00 € | ||
| 50mg | 78.00 € | ||
| 100mg | 104.00 € | ||
| 250mg | 208.00 € | ||
| 500mg | 312.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
Product Information
Name:
Ruxolitinib
Synonyms:
- (β-R)-β-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrileINCB 018424
- (3R)-3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile
- (Betar)-Beta-Cyclopentyl-4-(7H-Pyrrolo(2,3-D)Pyrimidin-4-Yl)-1H-Pyrazole-1-Propanenitrile
- (R)-3-[4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-cyclopentylpropanenitrile
- (βR)-β-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile
- 1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βR)-
- Inc 424
- Incb-018424
- R-Incb018424
- R-Ruxolitinib
- See more synonyms
- Ruxolitinib (INCB 018424)
- Ruxolitinib phosphate salt
CAS:
Description:
Ruxolitinib is a janus tyrosine kinase inhibitor active specifically on sub-types JAK1 and JAK2 with IC50 values in the nanomolar range. JAK1 and JAK2 are kinases involved in the regulation of hematopoiesis. Clinically applied to the treatment of intermediate and high-risk myelofibrosis, ruxolitinib is usually well tolerated by patients.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
306.37 g/mol
Formula:
C17H18N6
Purity:
Min. 95%
Color/Form:
White Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 3D-FR27771 Ruxolitinib
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
